Glucos. B. Braun (Glucose Monohydrate)

Glucos. B. Braun is an intravenous solution for injection that contains glucose monohydrate as the active ingredient. The product is supplied in a sterile liquid form, with the glucose concentration not detailed in the summary, and is marketed in the European Union. Classified as an excipient and a parenteral carbohydrate solution, it requires a prescription and is administered by healthcare professionals in clinical settings today.

Glucos. B. Braun is used in medical practice to provide rapid carbohydrate delivery and fluid balance in several clinical situations.

- Fluid and electrolyte replacement in patients requiring intravenous therapy. - Parenteral nutrition as an energy source when oral intake is insufficient. - Treatment of hypoglycemia to raise blood glucose levels quickly. - Support during surgery or critical care when carbohydrate intake is needed. - Dilution medium for compatible intravenous medications.

Adverse reactions to Glucos. B. Braun are generally related to the intravenous administration of a glucose solution and may vary in frequency and severity.

Common: - Mild hyperglycemia with transient elevation of blood glucose. - Local irritation or pain at the injection site. - Nausea or mild gastrointestinal discomfort. - Electrolyte shifts such as mild hyponatremia.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Fluid overload causing pulmonary edema. - Allergic reactions including rash, urticaria, or anaphylaxis. - Metabolic acidosis in patients with impaired lactate clearance.

When prescribing or administering Glucos. B. Braun, clinicians should consider several precautionary measures to ensure patient safety and optimal therapeutic effect.

- Assess blood glucose and electrolyte status before initiation. - Use caution in patients with renal or cardiac failure due to risk of fluid overload. - Monitor for signs of hyperglycemia during and after infusion. - Adjust infusion rate in individuals with impaired glucose tolerance or diabetes. - Avoid rapid infusion in neonates and infants. - Verify compatibility with other intravenous drugs before co‑administration. - Document any adverse reactions promptly.

Glucose solutions can interact with other medications or clinical conditions; awareness of these interactions helps prevent complications.

Avoid: - Concurrent administration with high‑dose insulin without glucose monitoring. - Co‑infusion with potassium chloride solutions that may cause precipitation. - Use with medications that require strict fluid restriction (e.g., certain diuretics) without adjustment.

Use with caution: - Concurrent use of beta‑blockers, which may mask hypoglycemia symptoms. - Administration with vasopressors, requiring careful hemodynamic monitoring. - Co‑administration with other hyperosmolar solutions, monitoring for electrolyte disturbances.